4//SEC Filing
Rosenblum Mark J 4
Accession 0001615219-23-000025
CIK 0001615219other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:06 PM ET
Size
4.9 KB
Accession
0001615219-23-000025
Insider Transaction Report
Form 4
Rosenblum Mark J
Exec VP Finance, CFO
Transactions
- Award
Common Stock
2023-02-13+6,432→ 21,851 total
Footnotes (1)
- [F1]Restricted stock granted under the Salarius Pharmaceuticals, Inc. 2015 Equity Incentive Plan in lieu of cash for performance bonus. The shares of common stock are subject to a six-month holding period pursuant to the terms of the restricted stock agreement
Documents
Issuer
Salarius Pharmaceuticals, Inc.
CIK 0001615219
Entity typeother
Related Parties
1- filerCIK 0001329154
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 4:06 PM ET
- Size
- 4.9 KB